@article {D{\textquoteright}Onofrio2021.06.16.21259042, author = {Valentino D{\textquoteright}Onofrio and Dries Heylen and Murih Pusparum and Inge Grondman and Johan Vanwalleghem and Agnes Meersman and Reinoud Cartuyvels and Peter Messiaen and Leo AB Joosten and Mihai G. Netea and Dirk Valkenborg and G{\"o}khan Ertaylan and Inge C. Gyssens}, title = {A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis}, elocation-id = {2021.06.16.21259042}, year = {2021}, doi = {10.1101/2021.06.16.21259042}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Sepsis is a life-threatening organ dysfunction. A fast diagnosis is crucial for patient management. Proteins that are synthesized during the inflammatory response can be used as biomarkers, helping in a rapid clinical assessment or an early diagnosis of infection. The aim of this study was to identify biomarkers of inflammation for the diagnosis and prognosis of infection in patients with suspected sepsis.Methods In total 406 episodes were included in a prospective cohort study. Plasma was collected from all patients on the first day of a new episode. Samples were analysed using a 92-plex proteomic panel based on a proximity extension assay with oligonucleotide-labelled antibody probe pairs (OLink, Uppsala, Sweden). Supervised and unsupervised differential expression analyses and pathway enrichment analyses were performed.Results Supervised differential expression analysis revealed 21 proteins that were significantly lower in circulation of patients with viral infections compared to patients with bacterial infections. More strongly, higher expression levels were observed for 38 proteins in patients with high SOFA scores (\>4), and for 21 proteins in patients with worse outcome. These proteins are mostly involved in pathways known to be activated early in the inflammatory response. Unsupervised, hierarchical clustering confirmed that inflammatory response was more strongly related to disease severity than to aetiology.Conclusion Several differentially expressed inflammatory proteins were identified that could be used as biomarkers for sepsis. These proteins are mostly related to disease severity. Within the setting of an emergency department, they could be used for outcome prediction, patient monitoring, and directing diagnostics.Registration clinicaltrial.gov identifier NCT03841162Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03841162Funding StatementThis study is part of the FAPIC project and has received funding from the European Union Horizon 2020 research and innovation program under GA 634137.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Documented approval for this study was obtained from the Ethics committees of Hasselt University and Jessa Hospital [18.106/infect18.03 and 19.51/infect.19.02]. Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and analyzed during the current study are available from the corresponding author on reasonable request. The data are not publicly available due to them containing information that could compromise research participant privacy/consent.}, URL = {https://www.medrxiv.org/content/early/2021/06/21/2021.06.16.21259042}, eprint = {https://www.medrxiv.org/content/early/2021/06/21/2021.06.16.21259042.full.pdf}, journal = {medRxiv} }